Psychedelics FDA gives another one of Filament Health’s psilocybin trials green light The news follows the agency approving a Phase 2 study on PEX010 for different indications in April Rowan Dunne17 hours ago
Psychedelics One dose of psilocybin can alleviate depression for 5 years, U.S. researchers find The finding came from follow up with participants from a 2020 magic mushroom study Rowan DunneJune 27, 2025
Psychedelics New Zealand gives green light to prescribe magic mushrooms for depression The nation has now joined Australia in this regard Rowan DunneJune 19, 2025
Psychedelics Texas makes its mark on psychedelics sector with US$50M in ibogaine research funding It's being called the largest publicly-funded psychedelic research initiative in history Rowan DunneMay 22, 2025
Sleep Elemind’s new partnership with Deepak Chopra merges sleep tech with guided meditation It's a spiritual snooze-promoting game changer Rowan DunneMarch 10, 2025
Psychedelics Psilocybin shows great promise for brain recovery after head injuries in rodents These findings are reinforced by the growing popularity of psychedelics among athletes who have had multiple concussions Rowan DunneMarch 6, 2025
Psychedelics Colorado set to ring in new year with regulated magic mushroom therapy A law passed by voters in late 2022 is coming into force on Jan. 1 Rowan DunneDecember 30, 2024
Sleep Deep Sleep Technologies to unveil brainwave-modulating tech in Las Vegas It will be making its grand debut at next year's Consumer Electronics Show Rowan DunneDecember 27, 2024
Psychedelics Psychedelic drug developer MindMed set for listing on Nasdaq Biotechnology Index MindMed's lead drug candidate is an LSD-like therapeutic used to treat anxiety Rowan DunneDecember 20, 2024
Psychedelics Australian gets life sentence for murdering mother in psychedelic drug psychosis Highly unlikely that you've ever heard of a person doing something worse under the influence Rowan DunneNovember 29, 2024